50
Views
4
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

Serum myeloperoxidase in cystic fibrosis patients receiving systemic antibiotics

, &
Pages 163-166 | Received 30 May 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vihas T. Vasu, Sharon J. de Cruz, Jessica S. Houghton, Keri A. Hayakawa, Brian M. Morrissey, Carroll E. Cross & Jason P. Eiserich. (2011) Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase. Free Radical Research 45:2, pages 165-176.
Read now

Articles from other publishers (3)

Zsolt Bene, Zsolt Fejes, Milan MacekJr.Jr., Margarida D. Amaral, István Balogh & Béla NagyJr.Jr.. (2020) Laboratory biomarkers for lung disease severity and progression in cystic fibrosis. Clinica Chimica Acta 508, pages 277-286.
Crossref
Ruchi Yadav, Dae-goon Yoo, J. Michelle Kahlenberg, S. Louis BridgesJrJr, Oluwadamilola Oni, Hanwen Huang, Arlene Stecenko & Balázs Rada. (2019) Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis. Journal of Cystic Fibrosis 18:5, pages 636-645.
Crossref
Alborz Hakimi Shoki, Nicole Mayer-Hamblett, Pearce G. Wilcox, Don D. Sin & Bradley S. Quon. (2013) Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations. Chest 144:5, pages 1659-1670.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.